TY - JOUR
T1 - Effects of DFMO on glioma cell proliferation, migration and invasion in vitro
AU - Terzis, A. Jorge A.
AU - Pedersen, Paal Henning
AU - Feuerstein, Burt G.
AU - Arnold, Hans
AU - Bjerkvig, Rolf
AU - Deen, Dennis F.
N1 - Funding Information:
This work was supported by grants from the Department of Neurosurgery, Lübeck, the Norwegian Cancer Society, a donations from Inger Margrethe and Per Jaeger, Frank Mohn A/S, and the Norwegian Research Council.
PY - 1998
Y1 - 1998
N2 - The polyamine inhibitor DL-α-difluoromethylomithine (DFMO) is a specific irreversible inhibitor of ornithine decarboxylase which is a rate-limiting enzyme in the polyamine bio-synthesis pathway. The present study describes the effects of DFMO on glioma cell proliferation, migration and invasion using multicellular spheroids from three glioma cell lines (GaMg, U-251 Mg and U-87 Mg). 10 mM DFMO reduced cell migration in the three cell lines by about 30-50%. 1 mM putrescine, added together with DFMO inhibited the DFMO effect. A stronger effect was observed in the growth assay where 10 mM DFMO reduced the spheroid growth, for all cell lines, by 90%. This effect was also reversed by adding 1 mM of putrescine. In vitro tumor cell invasion experiments indicated after 3 days of confrontation, an extensive invasion also after 10 mM DFMO treatment. The brain aggregate volumes were reduced to about the same extent as in the absence of drug, suggesting essentially no effects of DFMO on the invasive process. It is concluded that the tumor spheroids retained their ability to invade normal brain tissue even after DFMO exposure. However, DFMO inhibited spheroid growth and cell migration which supports the notion that cell growth, migration and invasion are biological properties that are not necessarily related to each other.
AB - The polyamine inhibitor DL-α-difluoromethylomithine (DFMO) is a specific irreversible inhibitor of ornithine decarboxylase which is a rate-limiting enzyme in the polyamine bio-synthesis pathway. The present study describes the effects of DFMO on glioma cell proliferation, migration and invasion using multicellular spheroids from three glioma cell lines (GaMg, U-251 Mg and U-87 Mg). 10 mM DFMO reduced cell migration in the three cell lines by about 30-50%. 1 mM putrescine, added together with DFMO inhibited the DFMO effect. A stronger effect was observed in the growth assay where 10 mM DFMO reduced the spheroid growth, for all cell lines, by 90%. This effect was also reversed by adding 1 mM of putrescine. In vitro tumor cell invasion experiments indicated after 3 days of confrontation, an extensive invasion also after 10 mM DFMO treatment. The brain aggregate volumes were reduced to about the same extent as in the absence of drug, suggesting essentially no effects of DFMO on the invasive process. It is concluded that the tumor spheroids retained their ability to invade normal brain tissue even after DFMO exposure. However, DFMO inhibited spheroid growth and cell migration which supports the notion that cell growth, migration and invasion are biological properties that are not necessarily related to each other.
KW - DFMO
KW - Glioma
KW - Invasiveness
KW - Polyamines
KW - Three dimensional culture
UR - http://www.scopus.com/inward/record.url?scp=0031930180&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031930180&partnerID=8YFLogxK
U2 - 10.1023/A:1005811403041
DO - 10.1023/A:1005811403041
M3 - Article
C2 - 9525811
AN - SCOPUS:0031930180
SN - 0167-594X
VL - 36
SP - 113
EP - 121
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 2
ER -